1. Home
  2. PHGE vs ILAG Comparison

PHGE vs ILAG Comparison

Compare PHGE & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • ILAG
  • Stock Information
  • Founded
  • PHGE 2015
  • ILAG 1981
  • Country
  • PHGE Israel
  • ILAG Hong Kong
  • Employees
  • PHGE N/A
  • ILAG N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • ILAG Office Equipment/Supplies/Services
  • Sector
  • PHGE Health Care
  • ILAG Consumer Discretionary
  • Exchange
  • PHGE Nasdaq
  • ILAG Nasdaq
  • Market Cap
  • PHGE 13.3M
  • ILAG 15.9M
  • IPO Year
  • PHGE N/A
  • ILAG 2022
  • Fundamental
  • Price
  • PHGE $0.74
  • ILAG $0.85
  • Analyst Decision
  • PHGE Strong Buy
  • ILAG
  • Analyst Count
  • PHGE 2
  • ILAG 0
  • Target Price
  • PHGE $13.50
  • ILAG N/A
  • AVG Volume (30 Days)
  • PHGE 110.1K
  • ILAG 39.9K
  • Earning Date
  • PHGE 11-14-2024
  • ILAG 12-20-2024
  • Dividend Yield
  • PHGE N/A
  • ILAG N/A
  • EPS Growth
  • PHGE N/A
  • ILAG N/A
  • EPS
  • PHGE N/A
  • ILAG N/A
  • Revenue
  • PHGE N/A
  • ILAG $8,980,747.00
  • Revenue This Year
  • PHGE N/A
  • ILAG N/A
  • Revenue Next Year
  • PHGE N/A
  • ILAG N/A
  • P/E Ratio
  • PHGE N/A
  • ILAG N/A
  • Revenue Growth
  • PHGE N/A
  • ILAG 33.03
  • 52 Week Low
  • PHGE $0.48
  • ILAG $0.33
  • 52 Week High
  • PHGE $8.55
  • ILAG $1.35
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 54.26
  • ILAG 45.00
  • Support Level
  • PHGE $0.70
  • ILAG $0.84
  • Resistance Level
  • PHGE $0.80
  • ILAG $0.92
  • Average True Range (ATR)
  • PHGE 0.06
  • ILAG 0.05
  • MACD
  • PHGE 0.00
  • ILAG 0.00
  • Stochastic Oscillator
  • PHGE 41.18
  • ILAG 30.13

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.

Share on Social Networks: